KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Inventory Average (2019 - 2025)

Historic Inventory Average for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to $8.5 million.

  • Castle Biosciences' Inventory Average rose 1666.78% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 1666.78%. This contributed to the annual value of $8.0 million for FY2024, which is 3485.15% up from last year.
  • Castle Biosciences' Inventory Average amounted to $8.5 million in Q3 2025, which was up 1666.78% from $7.6 million recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Inventory Average peaked at $8.5 million during Q3 2025, and registered a low of $2.2 million during Q1 2022.
  • In the last 5 years, Castle Biosciences' Inventory Average had a median value of $5.3 million in 2023 and averaged $5.1 million.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 9446.35% in 2023, then crashed by 386.86% in 2025.
  • Over the past 5 years, Castle Biosciences' Inventory Average (Quarter) stood at $2.2 million in 2021, then skyrocketed by 77.02% to $3.9 million in 2022, then surged by 76.19% to $6.9 million in 2023, then grew by 7.26% to $7.4 million in 2024, then grew by 15.7% to $8.5 million in 2025.
  • Its Inventory Average was $8.5 million in Q3 2025, compared to $7.6 million in Q2 2025 and $7.5 million in Q1 2025.